1. Home
  2. IDYA vs GPK Comparison

IDYA vs GPK Comparison

Compare IDYA & GPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$32.85

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Logo Graphic Packaging Holding Company

GPK

Graphic Packaging Holding Company

SELL

Current Price

$8.60

Market Cap

3.1B

ML Signal

SELL

Company Overview

Basic Information
Metric
IDYA
GPK
Founded
2015
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.1B
IPO Year
2019
2007

Fundamental Metrics

Financial Performance
Metric
IDYA
GPK
Price
$32.85
$8.60
Analyst Decision
Strong Buy
Hold
Analyst Count
16
12
Target Price
★ $52.29
$10.95
AVG Volume (30 Days)
840.4K
★ 6.6M
Earning Date
11-03-2026
11-03-2026
Dividend Yield
N/A
★ 5.04%
EPS Growth
★ 61.90
N/A
EPS
N/A
★ N/A
Revenue
$218,710,000.00
★ $8,617,000,000.00
Revenue This Year
N/A
$0.07
Revenue Next Year
$189.87
$1.84
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 3024.43
N/A
52 Week Low
$26.81
$8.16
52 Week High
$42.68
$18.25

Technical Indicators

Market Signals
Indicator
IDYA
GPK
Relative Strength Index (RSI) 27.61 37.34
Support Level $29.74 N/A
Resistance Level $35.14 $10.04
Average True Range (ATR) 1.29 0.28
MACD -0.43 0.05
Stochastic Oscillator 5.25 36.86

Price Performance

Historical Comparison
IDYA
GPK

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About GPK Graphic Packaging Holding Company

Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Americas Paperboard Packaging, and International Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company operates in Americas, Europe and Asia Pacific regions.

Share on Social Networks: